Bloodwork question about tirzepatide. Baseline, two months in, and the numbers moved in a direction I did not expect.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Titration is slow by design and rushing it is how people end up miserable.
What would change your mind about this?
What is the first thing you would read if you were starting from zero?
Name the active ingredient, not just the brand. It makes these threads searchable years later.
Same here.
Baseline first.
Test one thing at a time. It feels slower and it is the only way to learn anything. Same for me with tirzepatide, unfortunately.
Baseline first. Without a baseline the after picture is decoration. Not on tirzepatide but the pattern is familiar.
How long before you can reasonably say something is or is not doing anything? Same for me with tirzepatide, unfortunately.
Narrow conclusion.
This board overrates bloodwork. A number moving is not the outcome you wanted.
How long before you can reasonably say something is or is not doing anything?